§ 13F · FUND PROFILE
ACORN CAPITAL ADVISORS, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 21Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$295.1T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | TERN | TERNS PHARMACEUTICALS INC | 1.75M | $70.5T | 23.9% | NEW |
| 2 | CGON | CG ONCOLOGY INC | 1.13M | $47.0T | 15.9% | NEW |
| 3 | URGN | UROGEN PHARMA LTD | 1.45M | $33.9T | 11.5% | NEW |
| 4 | TRVI | TREVI THERAPEUTICS INC | 2.14M | $26.9T | 9.1% | NEW |
| 5 | PBYI | PUMA BIOTECHNOLOGY INC | 4.13M | $24.6T | 8.3% | NEW |
| 6 | CADL | CANDEL THERAPEUTICS INC | 2.58M | $14.6T | 4.9% | NEW |
| 7 | HELP | CYBIN INC | 1.57M | $12.9T | 4.4% | NEW |
| 8 | VSTM | VERASTEM INC | 1.47M | $11.3T | 3.8% | NEW |
| 9 | BCAX | BICARA THERAPEUTICS | 643K | $10.8T | 3.7% | NEW |
| 10 | TARA | PROTARA THERAPEUTICS INC | 1.75M | $9.3T | 3.2% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ACORN SIGNAL
AC read
ACORN CAPITAL ADVISORS, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
4 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed
Q4 2024
Steady book
+0 buys · −0 exits · 0 changed